New Hepatitis C Point-of-Care Test Shows Promise Despite High Costs
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
The proposed order would shift these test systems to Class II with special controls, replacing the current PMA requirement for companion diagnostics and related oncology assays.
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MoreA novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read MoreA study of 1,000 newborns found that genomic testing could identify hundreds of additional childhood conditions using the same blood sample from a heel-prick test.
Read MoreThe optimized protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kit for clinical research and precision medicine applications.
Read MoreWasatch BioLabs expands service portfolio with pharmacogenomics panel, telomere sequencing, and mRNA vaccine quality control workflows.
Read MoreNew materials aim to help patients and providers understand emerging molecular diagnostic tools for hypertensive disorders of pregnancy.
Read MoreBEACONS, a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in US newborn screening.
Read MoreThe companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Read MoreNew research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read MoreThe French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read MoreThe collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read MoreThe collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.
Read MoreThe program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.
Read MoreThe updated solutions leverage PacBio’s HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test.
Read MoreThe service applies CLSI M100 guidelines to PCR reports, delivering insights on pathogens and resistance markers to support labs and physicians.
Read More